Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Precision Biosciences (DTIL) Other Non-Current Assets (2018 - 2025)

Historic Other Non-Current Assets for Precision Biosciences (DTIL) over the last 8 years, with Q3 2025 value amounting to $26.3 million.

  • Precision Biosciences' Other Non-Current Assets rose 1668.14% to $26.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $26.3 million, marking a year-over-year increase of 1668.14%. This contributed to the annual value of $22.6 million for FY2024, which is 994444.44% up from last year.
  • Latest data reveals that Precision Biosciences reported Other Non-Current Assets of $26.3 million as of Q3 2025, which was up 1668.14% from $22.6 million recorded in Q2 2025.
  • Over the past 5 years, Precision Biosciences' Other Non-Current Assets peaked at $26.3 million during Q3 2025, and registered a low of $225000.0 during Q4 2023.
  • Moreover, its 5-year median value for Other Non-Current Assets was $4.6 million (2021), whereas its average is $9.4 million.
  • As far as peak fluctuations go, Precision Biosciences' Other Non-Current Assets tumbled by 9817.75% in 2023, and later surged by 994444.44% in 2024.
  • Precision Biosciences' Other Non-Current Assets (Quarter) stood at $4.6 million in 2021, then surged by 166.02% to $12.3 million in 2022, then tumbled by 98.18% to $225000.0 in 2023, then surged by 9944.44% to $22.6 million in 2024, then rose by 16.56% to $26.3 million in 2025.
  • Its last three reported values are $26.3 million in Q3 2025, $22.6 million for Q2 2025, and $22.6 million during Q1 2025.